Fungal keratitis Medical Services in China

Fungal keratitis is a serious, vision-threatening infection of the cornea caused by filamentous fungi (e.g., Fusarium, Aspergillus) or yeasts (e.g., Candida). It typically arises following corneal trauma—especially with plant or organic matter—and is more prevalent in warm, humid climates. Symptoms include persistent eye pain, photophobia, blurred vision, redness, and a characteristic feathery or satellite lesion pattern on slit-lamp examination. Diagnosis requires high clinical suspicion, corneal scraping for microbiological culture and PCR, and often confocal microscopy to visualize fungal hyphae. Treatment is challenging: topical antifungals (e.g., natamycin 5%, amphotericin B 0.15%) are first-line but require prolonged administration (weeks to months); oral antifungals (e.g., voriconazole) may be added for deep or refractory cases. Delayed diagnosis or inadequate therapy frequently leads to corneal perforation, endophthalmitis, or enucleation.

China offers distinct advantages for fungal keratitis management: rapid access to specialized ocular microbiology labs with same-day confocal imaging and multiplex PCR; standardized, evidence-based treatment protocols endorsed by the Chinese Ophthalmological Society; and integrated surgical capacity—including therapeutic keratoplasty and customized amniotic membrane transplantation—within 48 hours when medically indicated. Leading centers such as Zhongshan Ophthalmic Center (Guangzhou) and Shanghai Eye, Ear, Nose and Throat Hospital report >92% microbiological identification rates and >85% corneal salvage rates in severe cases, including multi-drug-resistant Fusarium infections successfully treated with combination voriconazole–natamycin regimens and adjunctive collagen cross-linking.

Treatment Options & Itemized Cost Breakdown: Fungal Keratitis

Non-Surgical (Conservative) Medical Therapy

*Target criteria*: Early-stage infection (<72h onset), ≤3 mm infiltrate, no endothelial involvement, culture-confirmed *Fusarium* or *Aspergillus*.

• •Topical antifungals

- Amphotericin B 0.15% ophthalmic solution: ¥320–¥380/bottle (≈ $45–$53)

• •Adjunctive therapy

- Preservative-free artificial tears (3x/day): ¥90–¥130/bottle (≈ $13–$18)

• •Diagnostic & monitoring fees

- Serial slit-lamp photography (per visit): ¥80–¥110 (≈ $11–$15) - Confocal microscopy (single session): ¥420–¥490 (≈ $59–$69)

Surgical/Procedural Interventions

*Eligibility*: Progressive stromal melt (>0.5 mm/day), descemetocele, perforation risk, or failure of 72h medical therapy.

• •Therapeutic corneal debridement

- Local anesthesia (topical + subconjunctival): ¥180–¥230 (≈ $25–$32)

• •Corneal transplant

- Deep anterior lamellar keratoplasty (DALK): ¥21,000–¥24,800 (≈ $2,940–$3,470)

• •Preoperative workup

- Pre-op OCT + endothelial cell count: ¥620–¥750 (≈ $87–$105)

Special/Complex Condition Management

• •Endophthalmitis extension: Intravitreal voriconazole (100 µg/0.1 mL) + pars plana vitrectomy — ¥15,200–¥17,800 (≈ $2,130–$2,490)
• •Diabetic or immunocompromised patients: Extended natamycin + oral voriconazole (200 mg BD × 14d) — drug cost: ¥2,800–¥3,400 (≈ $392–$476)
• •Recurrent infection post-transplant: Adjunctive topical caspofungin 0.05% — compounded formulation: ¥1,100–¥1,400/bottle (≈ $154–$196)

Quick Selection Guide

• •Mild, young adult (<45), budget-conscious: Natamycin monotherapy + KOH/culture — Total ≈ $120–$180
• •Moderate, diabetic or elderly (>65): Natamycin + confocal monitoring + oral voriconazole — Total ≈ $520–$710
• •Severe, perforation imminent: Therapeutic debridement + PKP — Total ≈ $3,000–$3,600
• •Immunosuppressed with recurrence: DALK + intracameral amphotericin + caspofungin — Total ≈ $4,100–$4,900